• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赶超肺炎球菌:肺炎球菌荚膜抗原刺激后最初几天的抗体动态。

Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.

机构信息

Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.

Respiratory & Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Sci Rep. 2018 Oct 18;8(1):15376. doi: 10.1038/s41598-018-33735-x.

DOI:10.1038/s41598-018-33735-x
PMID:30337597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6193966/
Abstract

Children in developing countries are frequently exposed to the pneumococcus, but few develop invasive pneumococcal disease (IPD). We test the hypothesis that natural variation exists in the rapidity of IgG responses following exposure to pneumococcal polysaccharides, and that these differences are sufficiently great to affect susceptibility to and outcome of IPD. We recruited children aged 24-36 months, who had recovered from IPD, and age-matched healthy controls and vaccinated them with 1 dose of the 23-valent PPV to mimic natural exposure. We collected serum samples after vaccination and analysed the dynamics of anti-polysaccharide antibody responses to several capsular antigens. Mean IgG response times to different serotypes were 6.4-7.3 days, with standard deviations of 0.9-1.85 days, suggesting a natural range in response times of up to 7 days. Serotype 1 elicited the largest fold-rise, serotype 23F the smallest. The proportion of responses achieved by day 7 was similar in children with a history of IPD and healthy children. There was considerable natural variation in the rapidity of anti-capsular IgG responses extending over 4-7 days. There was no evidence to suggest that children who have experienced IPD respond more slowly to heterologous pneumococcal capsular antigens than do healthy children.

摘要

发展中国家的儿童经常接触肺炎球菌,但很少发生侵袭性肺炎球菌病(IPD)。我们验证了这样一个假设,即在接触肺炎球菌多糖后,IgG 反应的速度存在自然变异,并且这些差异足够大,会影响 IPD 的易感性和结果。我们招募了年龄在 24-36 个月、已从 IPD 中康复的儿童和年龄匹配的健康对照者,并给他们接种一剂 23 价肺炎球菌多糖疫苗(PPV),以模拟自然接触。我们在接种后采集血清样本,并分析针对几种荚膜抗原的抗多糖抗体反应的动力学。对不同血清型的 IgG 反应时间平均为 6.4-7.3 天,标准差为 0.9-1.85 天,表明反应时间的自然范围可达 7 天。血清型 1 引起的倍数上升最大,血清型 23F 引起的倍数上升最小。有 IPD 病史的儿童和健康儿童在第 7 天达到反应的比例相似。抗荚膜 IgG 反应的速度存在相当大的自然变异,可延长至 4-7 天。没有证据表明经历过 IPD 的儿童对异源肺炎球菌荚膜抗原的反应速度比健康儿童慢。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/b2c56ba2ae6c/41598_2018_33735_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/d666f67750cd/41598_2018_33735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/ed963cde8b97/41598_2018_33735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/b2c56ba2ae6c/41598_2018_33735_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/d666f67750cd/41598_2018_33735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/ed963cde8b97/41598_2018_33735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d781/6193966/b2c56ba2ae6c/41598_2018_33735_Fig3_HTML.jpg

相似文献

1
Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.赶超肺炎球菌:肺炎球菌荚膜抗原刺激后最初几天的抗体动态。
Sci Rep. 2018 Oct 18;8(1):15376. doi: 10.1038/s41598-018-33735-x.
2
Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease.儿童感染侵袭性肺炎球菌疾病后,接种 7 价肺炎球菌结合疫苗对感染血清型反应低下。
Vaccine. 2014 Mar 14;32(13):1444-50. doi: 10.1016/j.vaccine.2014.01.031. Epub 2014 Jan 29.
3
Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.7价肺炎球菌结合疫苗(PCV7)在委内瑞拉有侵袭性肺炎球菌疾病风险儿童中的免疫原性及其对携带情况的影响。
Vaccine. 2014 Jun 30;32(31):4006-11. doi: 10.1016/j.vaccine.2014.04.027. Epub 2014 May 14.
4
The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.人类免疫缺陷病毒感染的泰国儿童中肺炎球菌结合疫苗的免疫原性和安全性。
Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3.
5
Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.疫苗接种前时代针对13种疫苗血清型的肺炎球菌抗体的动力学和决定因素
PLoS One. 2016 Jan 21;11(1):e0147437. doi: 10.1371/journal.pone.0147437. eCollection 2016.
6
Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.体液免疫正常和异常儿童的总肺炎球菌抗体滴度及血清型特异性肺炎球菌抗体滴度
Vaccine. 2006 Jul 7;24(27-28):5637-44. doi: 10.1016/j.vaccine.2006.03.088. Epub 2006 Apr 18.
7
Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.既往接种肺炎球菌结合疫苗对肺炎球菌多糖疫苗抗体反应的影响。
Clin Exp Immunol. 2016 Aug;185(2):180-9. doi: 10.1111/cei.12784. Epub 2016 May 20.
8
Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.接种八价肺炎球菌结合疫苗、PncD和PncT的婴幼儿的血清和唾液抗荚膜抗体
Vaccine. 2001 Oct 12;20(1-2):194-201. doi: 10.1016/s0264-410x(01)00250-x.
9
Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013.2006-2013 年英国侵袭性肺炎球菌病患儿(免疫与未免疫者)针对感染血清型的抗体浓度。
Clin Infect Dis. 2015 Jun 15;60(12):1793-801. doi: 10.1093/cid/civ164. Epub 2015 Mar 3.
10
Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.魁北克使用三种不同肺炎球菌结合疫苗前后侵袭性肺炎球菌病的发病情况。
Vaccine. 2018 Jan 8;36(3):421-426. doi: 10.1016/j.vaccine.2017.11.054. Epub 2017 Dec 7.

本文引用的文献

1
Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France.法国儿童常规接种7价和13价肺炎球菌结合疫苗后的肺炎球菌性脑膜炎疫苗突破与失败情况
Pediatr Infect Dis J. 2015 Oct;34(10):e260-3. doi: 10.1097/INF.0000000000000818.
2
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.13 价肺炎球菌结合疫苗的血清型特异性效力和保护相关性:上市后间接队列研究。
Lancet Infect Dis. 2014 Sep;14(9):839-46. doi: 10.1016/S1473-3099(14)70822-9. Epub 2014 Jul 17.
3
Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.
10 价肺炎球菌/无荚膜流感嗜血杆菌蛋白 D 结合疫苗在肯尼亚 1-4 岁儿童中的免疫原性、携带影响和反应原性:一项随机对照试验。
PLoS One. 2014 Jan 21;9(1):e85459. doi: 10.1371/journal.pone.0085459. eCollection 2014.
4
Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study.血清抗体对生命头 2 年中肺炎球菌定植的反应:来自东南亚纵向队列研究的结果。
Clin Microbiol Infect. 2013 Dec;19(12):E551-8. doi: 10.1111/1469-0691.12286.
5
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis.13 价肺炎球菌结合疫苗在婴儿中的安全性和免疫原性:荟萃分析。
Vaccine. 2013 Nov 4;31(46):5349-58. doi: 10.1016/j.vaccine.2013.09.008. Epub 2013 Sep 19.
6
Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants.免疫原性后第一和第二剂量的 7 价肺炎球菌结合疫苗在 HIV 感染和未感染的婴儿。
Vaccine. 2013 Jan 21;31(5):777-83. doi: 10.1016/j.vaccine.2012.11.076. Epub 2012 Dec 8.
7
P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.P4 介导的抗体疗法在侵袭性肺炎球菌病的急性模型中。
J Infect Dis. 2012 May 1;205(9):1399-407. doi: 10.1093/infdis/jis223. Epub 2012 Mar 29.
8
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. trough IgG 对原发性免疫缺陷患者肺炎发病率的影响:临床研究的荟萃分析。
Clin Immunol. 2010 Oct;137(1):21-30. doi: 10.1016/j.clim.2010.06.012. Epub 2010 Aug 1.
9
An augmented passive immune therapy to treat fulminant bacterial infections.一种用于治疗暴发性细菌感染的增强型被动免疫疗法。
Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. doi: 10.2174/157489110791233496.
10
Invasive pneumococcal infections among vaccinated children in the United States.美国接种疫苗儿童中的侵袭性肺炎球菌感染。
J Pediatr. 2010 Mar;156(3):478-483.e2. doi: 10.1016/j.jpeds.2009.10.008. Epub 2009 Dec 3.